The effects of anti-idiotypic antibody on antibody production and apoptosis of anti-dsDNA antibody producing cells

Clinical and Experimental Rheumatology

Volumn 21, Issue 3, 2003, Pages 291-300

  Lee, Chan Hee ^b   Suh, Chang Hee ^b   Lee, Jisoo ^b   Kim, Young Tai ^a   Lee, Soo Kon ^b  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Anti dsDNA antibody; Anti idiotypic antibody; Apoptosis; Corticosteroid

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CALCIUM IONOPHORE; CORTICOSTEROID; DNA ANTIBODY; DOUBLE STRANDED DNA; FAS ANTIGEN; FAS LIGAND; IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G1-2; MONOCLONAL ANTIBODY M2-10; OXYGEN RADICAL; PHORBOL ESTER; PREDNISOLONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIBODY TITER; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; GENETIC TRANSCRIPTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINUCLEAR; ANTIBODY FORMATION; ANTIBODY-PRODUCING CELLS; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; PREDNISOLONE; SENSITIVITY AND SPECIFICITY;

EID: 0038548590     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. HAHN BR, TSAO BP: Antibodies to DNA. In WALLACE DJ, HAHN BH (Eds.): Dubois' Systemic Lupus Erythematosis. Philadelphia, Lea and Febiger 1993: 195-201.
2. TER BORG EJ, HORST G, HUMMEL EJ, LIMBURG PC, KALLENBERG CG: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term prospective study. Arthritis Rheum 1990; 33: 634-43.
3. SCHUR PR, SNADSON J: Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 1968; 278: 533-8.
4. BURDETTE S, SCHWARTZ RS: Idiotypes and idiotypic networks. N Engl J Med 1987; 317: 21924.
5. ABDOU NI, WALL H, LINDSLEY HB, HALSEY IF, SUSUKI T: Network theory in autoimniunity: In vitro suppression of serum anti-DNA antibody binding to DNA by antiidiotypic antibody in systemic lupus erythematosus. J Clin Invest 1981; 67: 1297-304.
6. HAHN BR, EBLING FM: Suppression of murine lupus nephritis by administration of an antiidiotypic antibody to anti-DNA. J Immunol 1984; 132: 187-90.
7. EPSTEIN A, GREENBERG M, DIAMOND B, GRAYZEL AI: Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotypic antibody. J Clin Invest 1987; 79: 9971000.
8. MAHANA W, GUILBERT B, AVRAMEAS S: Suppression of anti-DNA antibody production in NM mice by treatment with anti-idiotypic antibodies. Clin Exp Immunol 1987; 70: 538-45.
9. BLANK M, MANOSROI J, TOMER Y et al.: Suppression of experimental systemic lupus erythematosus with specific anti-idiotypic antibody-saporin conjugate. Clin Exp Immunol 1994; 98: 434-41.
10. SCOTT DW, LAMERS M, KOHLER G, SIDMAN GL, MADDOX B, CARSETTI R: Role of c-myc and CD45 in spontaneous and antireceptor-induced apoptosis in adult murine B cells. Int Immunol 1996; 8: 1375-85.
11. MOTYKA B, BHOGAL HS, REYNOLDS JD: Apoptosis of ileal Peyer's patch B cells increased by glucocorticoids or anti-immunoglobulin antibodies. Eur J Immunol 1995; 25: 1865-71.
12. STELLER H: Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-9.
13. AKBAR AN, SALMON M: Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death. Immunol Today 1997; 18: 72-6.
14. YANG J, LIU XS, BHALLA K et al.: Prevention of apoptosis by Bcl-2: Release of cytochrome C from mitochondria blocked. Science 1997; 275: 1129-32.
15. RENSCHLER MF, WADA HG, FOK KS, LEVY R: B-lymphocyte cells are activated by peptide ligands of the antigen binding receptor or by anti-Idiotypic antibody to induce extracellular acidification. Cancer Res 1995; 55: 5642-7.
16. WEISBART RH, COLBURN K: Effect of corticosteroids on serum antinuclear antibodies in man. Immunopharmacology 1984;8:97-101.
17. SEKI M, USHIYAMA C, SETA N et al.: Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 823-30.
18. PLANEY SL, LITWACK G: Glucocorticoid-induced apoptosis in lymphocytes. Biochem Biophys Res Commun 2000; 279: 307-12.
19. SCHWARTZMAN RA, CIDLOWSKI JA: Glucocorticoid-induced apoptosis of lymphoid cells. Int Arch Allergy Immunol 1994; 105: 347-54.
20. THEOFILOPOULOS A, DIXON FJ: Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269-90.
21. COHEN PL, EISENBERG RA: Lpr and gld: Single gene models of systemic autoimmumty and lymphoproliferative disease. Annu Rev Immunol 1991; 9: 234-69.
22. SHOENFELD Y, HSU-LIN SC, GABRIELS JE et al.: Production of autoantibodies by human-human hybridomas. J Clin Invest 1982; 70: 205-8.
23. PARK JS, KIM YT, LEE CH, YOUN JK, JANG YJ: Anti-DNA autoantibodies from an MRL/lpr mouse. Korean J Biol Sci 1998; 2: 371-5.
24. KIM YT, PUNTILLO E, DEBLASIO T, WEKSLER ME, SISKIND GW: Regulation of antibody production by hybridoma cell cultures. Cell Immunol 1987; 105: 65-74.
25. YI AK, HORNBECK P, LAFERENZ DE, KRIEG AM: CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. J Immunol 1996; 157: 4918-25.
26. CHLEQ-DESCHAMPS CM, LEBRUN DP et al.: Topographical dissociation of BCL2 messenger RNA and protein expression in human lymphoid tissues. Blood 1993; 81: 293-8.
27. WANG J, JERRELLS TR, SPITZER JJ: Decreased production of reactive oxygen intermediates is an early event during in vitro apoptosis of rat thymocytes. Free Radic Biol Med 1996; 20: 533-42.
28. JEME NK: Towards a network theory of the immune system. Ann Immunol Paris 1974; 125C: 373-89.
29. ZHANG W, WINKLER T, KALDEN JR, REICHLIN M: Isolation of human anti-idiotypes broadly cross reactive with anti-dsDNA antibodies from patients with systemic lupus erythematosus. Scand J Immunol 2001; 53: 192-7.
30. MURYOI T, SASAKI T, HARATA N, TAKAI O, TAMATE E, YOSHINAGA K: Heterogeneity of antiidiotypic antibodies to anti-DNA antibodies in humans. Clin Exp Immunol 1988; 71: 67-72.
31. KRAUSE I, BLANK M, KOPOLVIC J et al.: Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gammaglobulin. J Rheumatol 1995; 22: 1068-74.
32. LEVY Y, SHERER Y, AHMED A et al.: A study of 20 SLE patients with intravenous immunoglobulin - Clinical and serologic response. Lupus 1999; 8: 705-12.
33. ASHMAN RF, PECKHAM D, STUNZ LL: Fc receptor off-signal in the B cell involves apoptosis. J Immunol 1996; 157: 5-11.
34. RAVIRAJAN CT, SARRAF CE, ANIKUMAR TV, GOLDING MC, ALISON MR, ISENBERG DA: An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus(SLE). Clin Exp Immunol 1996; 105: 306-12.
35. MCDONNELL TI, DEANE N, PLATT FM, NUNEZ G, JAEGUR U, MCKEAM JP, KORSMEYER SJ: Bcl-2 immunoglobulin transgene mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 58: 79-88.